In the summer of 2020, NGen challenged companies to employ advanced manufacturing technologies to build a sustainable, made-in-Canada, cost competitive supply of critical products that can be used in Canada’s fight against COVID-19 and beyond.
New Manufacturing Capacity
The challenge funding supports twelve Canadian companies and their project partners, representing a total combined investment of over $60 million to develop advanced manufacturing projects. Product categories include a made-in-Canada mRNA vaccine, biological reagents, environmentally friendly PPE, sanitizers & antimicrobials, surgical grade masks and respirators.
Providence Therapeutics Holdings Inc., Toronto, ON
The BIG-nano Corporation., Waterloo, ON
McRae Imaging, Mississauga, ON
Fine Cotton Factory, Etobicoke, ON
Fidelity Machine & Mould, Calgary, AB
Prescientx, Cambridge, ON,
Molded Precision Components (MPC), Oro Medonte, ON
Titan Clean Energy Project Corp., Craik, SK,
Carmina De Young Fashion Design Inc., London, ON
Artofix, Longueuil, QC
International Point of Care INC. (IPOC), Toronto, ON
Novo Textiles, Coquitlam, BC
Read the full press release here